Zaderej Karen L. 4
4 · Axogen, Inc. · Filed Mar 25, 2024
Insider Transaction Report
Form 4
Axogen, Inc.AXGN
Zaderej Karen L.
DirectorChief Executive Officer
Transactions
- Sale
Common Stock
2024-03-21$7.68/sh−33,028$253,655→ 1,124,565 total - Exercise/Conversion
Common Stock
2024-03-16+12,500→ 1,137,065 total - Exercise/Conversion
Common Stock
2024-03-16+84,847→ 1,157,593 total - Sale
Common Stock
2024-03-21$7.68/sh−3,086$23,700→ 1,133,979 total - Exercise/Conversion
Common Stock
2024-03-16+12,975→ 1,146,954 total - Exercise/Conversion
Restricted Stock Units
2024-03-16−84,847→ 84,847 total→ Common Stock (84,847 underlying) - Exercise/Conversion
Restricted Stock Units
2024-03-16−12,500→ 12,500 total→ Common Stock (12,500 underlying) - Sale
Common Stock
2024-03-21$7.68/sh−3,166$24,315→ 1,143,788 total - Exercise/Conversion
Restricted Stock Units
2024-03-16−12,975→ 0 total→ Common Stock (12,975 underlying)
Footnotes (6)
- [F1]This reflects the number of restricted stock units that became vested as of March 16, 2024 .
- [F2]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.
- [F4]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2026 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregateshares vest on March 16, 2024 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F5]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2025 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2023 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.
- [F6]All shares of Axogen Inc. common stock underlying the restricted stock units will be fully vested on March 16, 2024 (4 years from the grant date) based upon a vesting schedule whereby 50% of the aggregate shares vest on March 16, 2022 (24 months from the grant date) and an additional 25% of the aggregate shares vest each 12 months thereafter. Vested shares will be delivered to the reporting person upon the vesting date.